Deriving the therapeutic concentrations for clozapine and haloperidol: The apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand

https://doi.org/10.1016/0922-4106(95)90125-6Get rights and content

Abstract

The apparent dissociation constant, Ki, for a neuroleptic at the dopamine D2 or D4 receptor was consistently higher when competed against [3H]nemonapride than against [3H]spiperone which was in turn higher than that against [3H]raclopride. This finding obtained for all four types of dopamine receptors studied, including the native dopamine D2 receptor in the anterior pituitary tissue, the human D2long receptor, the human D2short receptor and the human D4.4 receptor. Some neuroleptics revealed a difference of over 10-fold between the Ki using [3H]nemonapride and the Ki using [3H]raclopride. The KD values of the three 3H-ligands and the neuroleptic Ki values were lower when using a much lower concentration of tissue, indicating that depletion of ligand presumably accounted for the phenomenon. The Ki values of each neuroleptic were related to the the tissue/buffer partition coefficients of the three 3H-ligands. Extrapolating the neuroleptic Ki value down to a tissue/buffer partition coefficient of unity or zero led to a Ki value for competition versus a water-soluble ligand such as dopamine. Clozapine extrapolated to a Ki value of 1.3 nM. Direct measurement gave a Ki value of 1.6 nM for [3H]clozapine at the dopamine D4 receptor. When competing versus endogenous dopamine, this clozapine value of 1.6 nM would rise to 20 nM for the blockade of 75% of dopamine D4 receptors, matching the observed therapeutic concentration of 18 nM. These data also explain why clozapine occupies 48% of the D2 receptors in patients when measured with [11C]raclopride, but between 0% and 22% when measured with [18F]methylspiperone or [18F]fluoroethylspiperone.

References (20)

There are more references available in the full text version of this article.

Cited by (74)

  • Rationale and neurobiological effects of treatment with antipsychotics in patients with chronic schizophrenia considering dopamine supersensitivity

    2021, Behavioural Brain Research
    Citation Excerpt :

    The main mechanism of clozapine action has been proposed to be either a higher affinity receptor rate of 5-HT2A/DRD2, which is an atypical profile of the most extreme nature, and/or a faster dissociation from DRD2s [8,150]. The action of its main active metabolite (norclozapine) and the blockade of DRD4 by clozapine have been also discussed [151–153]. Despite these extensive studies and discussions, it remains uncertain whether these factors are involved in the efficacy of clozapine.

  • In vivo temporal EPR study using a region-selected intensity determination method to estimate cerebral reducing ability in rats treated with olanzapine

    2010, Magnetic Resonance Imaging
    Citation Excerpt :

    HPD shows a high affinity for D2 receptors, so HPD administration prompts dopamine turnover because of occupancy of D2 receptors by the neuroleptic [9,10,13,14]. A novel atypical neuroleptic, olanzapine (OZP), has a favorable side-effect profile, with minimal EPS, because of lower affinity for D2 receptors [14–17]. However, acute administration of OZP causes an increase in dopamine turnover, which is considered to reflect enhancement of intracerebral dopamine release [18].

View all citing articles on Scopus
View full text